Medical devices manufacturer ReWalk Robotics has received the European CE-Mark for the ReStore Exo-Suit as an assistive therapy for stroke rehabilitation.
ReStore features a soft, garment-like design to help improve movement along with plantarflexion propulsion assistance made to adaptively sync with the patient’s natural gait.
Go deeper with GlobalData
It is intended to enable functional gait training activities. In addition, therapists can use the device to adjust and optimise a patient’s treatment based on real-time analytics.
ReWalk Robotics CEO Larry Jasinski said: “The ReStore revolutionises post-stroke gait training, providing key advantage to clinics, therapists and patients.
“We developed this design through collaboration with the Wyss Institute at Harvard because of the unique opportunity to combine extensive depth of the supporting science and clinician involvement in designing the ideal system for stroke therapy in the clinic.”
Stroke is a leading cause of disability known to impact 17 million people globally each year.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataNearly 80% of stroke survivors experience locomotor dysfunction characterised by asymmetrical step length, slow velocity and altered biomechanical alignment.
The ReStore Exo-Suit has been designed to treat a wide range of stroke rehabilitation patients. ReWalk Robotics intends to price the device significantly lower than its first generation of exoskeleton technologies.
ReStore will be available through both direct purchase and third-party leasing programmes.
Jasinski added: “The device’s affordability and versatility make an attractive solution for a broader range of the rehabilitation market than previous technologies.
“Considering the high prevalence of stroke and the need for more effective and efficient clinical solutions, the marketplace for the ReStore is significant and holds immense promise for the continued innovation of care.”
ReStore follows the at-home robotic exoskeleton device ReWalk Personal 6.0, intended to help patients suffering from paralysis from a spinal cord injury.
